Scientific educational event currently limited to Standard Licensed Cultivators in Canada. Tests abilities by starting competitors with identical genetics and determines winners via objective analyses at an unbiased laboratory.
KITCHENER, ON, April 26, 2019 /CNW/ - Qualis Cannabis Corporation ("Qualis"), is pleased to announce that they have signed a Letter of Intent with The Grow-Off LLC. ("TGO"). This deal allows Qualis to operate the Canadian Edition of the event, via its subsidiary The Grow Off Inc. (thegrowoff.ca).
Under this agreement, The Grow-Off Inc. will run all events in accordance with all applicable Canadian, and provincial laws.
"We are excited to announce our deal with The Grow-Off LLC. This is the first competition of its kind in Canada. We can't wait to showcase Canadian growing expertise to the world."
-Kevin Puloski, CEO, Qualis Cannabis
First of its kind in Canada
Both Qualis and TGO are firmly committed to scientific & educational bases for cannabis innovation. This alignment will showcase expert panels, public and private events, and access to cutting edge producer tech and services. The event kicks off in Spring/Summer 2019 ending with a private awards ceremony in Fall/Winter, honoring the best in potency, flavor, and yield.
The Grow-Off's Canadian Edition is continually searching for sponsorship partners from genetics providers to laboratory testing services, and participants for the 2019 launch.
"We are very excited to bring this competition to Canada. Qualis Cannabis has impressed us with their dedication to the Cannabis space."
-Samantha Sandt, Founder and CEO, The Grow-Off
About The Grow-Off LLC.
Founded in 2016 and headquartered in Colorado, U.S.A., The Grow-Off (https://thegrowoff.com/) has run the event 7 times in its quantitative quest for the best.
TGO's founders designed an innovative educational event that pits growers against each other using the same genetic base-line with judging based entirely on lab testing. Following resounding successes across multiple US states, the Canadian expansion is set to highlight cultivators in the industry's first federally legal G7 nation.
About Qualis Cannabis
Qualis (https://qualis.ca/) is a boutique biotech company showcasing its skill in domestic and foreign markets via a number of cutting-edge projects that now includes The Grow-Off Inc.
Subsidiaries include Northern Roots Cannabis and its Genetics Initiative. They are forging brilliant cannabis products and production-ready varieties through scientific innovation and a unique fair-trade cannabis cultivar platform. The continual, ethically-based intake of varieties from breeders and growers, paired with leading methodologies, increases yield, potency, pest-resistance, and intellectual property protection for any cultivar in any growing condition. This will enable cannabis extract and isolate production at lower cost, with higher yield. Qualis has developed partnership agreements with international pharmaceutical companies that see the intersection of its model with global industry trends.
Qualis is committed to ethical and environmental sustainability, industry stewardship, cultural respect, economic innovation, and social responsibility. Qualis is currently working with educational institutions, community groups, and legacy breeders to bring unique, protected, and potent strains to the international market for production in diverse environments. Northern Roots' Cannabis Genetics Initiative currently represents a library of pre-validated strains. (http://www.northernroots.co/)
Cautionary Note Regarding Forward-looking Statements.
Certain statements in this news release may constitute "forward-looking" statements which involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.
SOURCE Qualis Cannabis Corp.
For further information: Press Contact: Julien Morris - Chief Product Officer, 519-880-1714 ext. 502